医疗保健分析测试服务市场规模、份额、成长分析（按类型、最终用户、地区）- 产业预测，2024-2031 年

Healthcare Analytical Testing Services Market Size, Share, Growth Analysis, By Type, By End User, By Region - Industry Forecast 2024-2031

出版日期: 2024年11月09日 | 出版商:

SkyQuest | 英文 168 Pages | 商品交期: 3-5个工作天内

价格

简介目录

2022年全球医疗保健分析测试服务市场规模约66.5亿美元，高于2023年的73.9亿美元，预测期间（2024-2031年）复合年增长率为11.2%，预计将达到155.5亿美元。年。

市场成长是由几个关键因素推动的，包括需要分析测试的临床试验数量的增加、对生物相似药的日益关注以及製药公司向外包分析测试服务的显着转变。 COVID-19大流行在该市场的扩张中发挥了重要作用。虽然居家订单和供应链中断最初导致经济放缓，但对疫苗和治疗的迫切需求最终刺激了成长。例如，SGS SA 与阿斯特捷利康于2020 年7 月的合作说明了对COVID-19 疫苗AZD1222 至关重要的分析测试服务的需求，以及此类服务如何促进风险降低、加速品质保证，并且我们已经证明，我们可以确保监管合规性。技术创新与检测服务需求增加之间的相关性是显而易见的，特别是随着生物相似药、组合药物和其他新型疗法的出现。此外，竞争加剧、快速进入市场的压力以及定价挑战正在促使製药公司外包这些测试服务。拓展新市场还需要满足当地监管要求，从而导致对特定类型测试的需求增加。随着对先进、可靠的分析测试的需求持续飙升，预计市场将保持成长轨迹。

市场概况
北美洲
- 美国
- 加拿大
欧洲
- 德国
- 西班牙
- 法国
- 英国
- 义大利
- 其他欧洲国家地区
亚太地区
- 中国
- 印度
- 日本
- 韩国
- 其他亚太地区
拉丁美洲
- 巴西
- 其他拉丁美洲地区
中东和非洲 (MEA)
- 海湾合作委员会国家
- 南非
- 其他中东/非洲地区

竞争格局

前5名企业对比
主要企业市场定位（2023年）
主要市场参与者所采取的策略
近期市集活动
主要企业市场占有率（2023年）

主要企业简介

Eurofins Scientific（Luxembourg）
Laboratory Corporation of America Holdings（US）
SGS SA（Switzerland）
Charles River Laboratories（US）
WuXi AppTec Co. Ltd.（China）
Element Materials Technology（UK）
Thermo Fisher Scientific, Inc.（US）
Pace Analytical Services LLC（US）
Intertek Group plc（UK）
IQVIA Inc.（US）
Merck KGaA（Germany）
Source BioScience（UK）
Almac Group（UK）
ICON Plc（Ireland）
Frontage Laboratories, Inc.（US）
STERIS Plc（US）
Sartorius AG（Germany）
ALS Life Science（US）
Syneos Health, INC（US）
Medpace Holdings, Inc.（US）

简介目录

Product Code: SQMIG35D2273

Global Healthcare Analytical Testing Services Market size was valued at around USD 6.65 billion in 2022 and is expected to rise from USD 7.39 billion in 2023 to reach a value of USD 15.55 billion by 2031, at a CAGR of 11.2% over the forecast period (2024-2031).

Market growth is driven by several key factors, including a rising number of clinical trials necessitating analytical testing, an increasing focus on biosimilars, and a notable shift towards outsourcing analytical testing services by pharmaceutical companies. The COVID-19 pandemic has played a significant role in this market's expansion; initially causing a slowdown due to stay-at-home orders and disruptions in supply chains, it ultimately spurred growth due to the urgent need for vaccines and treatments. For instance, the collaboration between SGS SA and AstraZeneca in July 2020 exemplified the demand for analytical testing services crucial for the COVID-19 vaccine AZD1222, demonstrating how such services can facilitate risk reduction, accelerate quality assurance, and ensure regulatory compliance. The correlation between innovations and the increased demand for testing services is evident, especially with the advent of biosimilars, combination products, and other novel therapeutics. Furthermore, intensified competition, pressures for quicker market entry, and pricing challenges are driving pharmaceutical firms to outsource these testing services. Expansion into new markets also necessitates meeting local regulatory requirements, resulting in an increased need for specific testing types. As demand for advanced and reliable analytical testing continues to surge, the market is expected to maintain its growth trajectory.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Healthcare Analytical Testing Services market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Healthcare Analytical Testing Services Market Segmental Analysis

Global Healthcare Analytical Testing Services Market is segmented by Type, End User, and Region. Based on Type, the market is segmented into Medical Device Analytical Testing Services (Extractable and Leachable, Material Characterization, Physical Testing, Bioburden Testing, Sterility Testing, Others), Pharmaceutical Analytical Testing Services (Bioanalytical Testing, Method Development & Validation, Stability Testing, Other Testing Services). Based on End User, the market is segmented into Pharmaceutical & Biopharmaceutical Companies, Medical Device Companies, Hospitals & Clinics, Forensic Labs, Cosmetic & Nutraceutical Companies. Based on Region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & and Africa.

Driver of the Global Healthcare Analytical Testing Services Market

The Global Healthcare Analytical Testing Services market is significantly driven by the rising demand for medical testing services, fueled by the surging aging population and the escalating prevalence of chronic diseases. This demand is further amplified by the advent of personalized medicine, which relies on sophisticated diagnostic testing and analytical services for tailored treatment approaches. Additionally, substantial investments from healthcare professionals and the biopharmaceutical sector in enhancing analytical testing capabilities have provided robust momentum to the market. As the necessity for accurate and dependable diagnostic results intensifies, the ongoing expansion and adoption of healthcare testing services are expected to persist, bolstering market growth.

Restraints in the Global Healthcare Analytical Testing Services Market

The Global Healthcare Analytical Testing Services market faces significant restraints primarily due to high pricing and operational complexity. The cost associated with advanced analytical testing, which includes specialized software, sophisticated equipment, and the necessity for expert personnel, can deter small and medium-sized enterprises from investing in these essential services. Moreover, the intricate nature of testing processes compounds the risk of errors and inconsistencies, potentially undermining the integrity of results. This financial and operational burden makes it challenging for smaller firms to compete effectively, ultimately stunting market growth as stakeholders must carefully consider the balance between investment costs and anticipated benefits.

Market Trends of the Global Healthcare Analytical Testing Services Market

The Global Healthcare Analytical Testing Services market is witnessing a significant shift towards outsourcing, driven by cost reduction, technological advancements, and a focus on core competencies among biotechnology and pharmaceutical firms. As companies seek to enhance productivity and streamline operations, they increasingly turn to specialized service providers for analytical testing, allowing them to leverage external expertise and accelerate turnaround times. This trend is expected to grow, fueled by a rising demand for comprehensive analytical testing services that meet strict regulatory standards. Consequently, the outsourcing model is reshaping the market landscape, fostering innovation and efficiency in the healthcare sector.

Introduction

Objectives of the Study
Definitions
Market Scope

Research Methodology

Information Procurement
Secondary & Primary Data Sources
Market Size Estimation
Market Assumptions & Limitations

Executive Summary

Market Overview Outlook
Supply Demand Trend Analysis
Segmental Opportunity Analysis

Market Dynamics & Outlook

Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges
Porters Analysis
- Competitive rivalry
- Threat of Substitute Products
- Bargaining Power of Buyers
- Threat of New Entrants
- Bargaining Power of Suppliers

Key Market Insights

Key Success Factor
Degree of Competition
Top Investment Pockets
Ecosystem of the Market
Value Chain Analysis
Case Study Analysis
Regulatory Landscape
Startup Analysis
Technology Analysis
Innovation Matrix
Market Attractiveness Index, 2023

Healthcare Analytical Testing Services Market, By Type

Market Overview
Medical Device Analytical Testing Services
- Extractable and Leachable
- Material Characterization
- Physical Testing
- Bioburden Testing
- Sterility Testing
- Others
Pharmaceutical Analytical Testing Services
- Bioanalytical Testing
- Method Development & Validation
- Stability Testing
- Other Testing Services

Healthcare Analytical Testing Services Market, By End User

Market Overview
Pharmaceutical & Biopharmaceutical Companies
Medical Device Companies
Hospitals & Clinics
Forensic Labs
Cosmetic & Nutraceutical Companies

Healthcare Analytical Testing Market Size by Region

Market Overview
North America
- USA
- Canada
Europe
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America
- Brazil
- Rest of Latin America
Middle East & Africa (MEA)
- GCC Countries
- South Africa
- Rest of MEA

Competitive Landscape

Top 5 Player Comparison
Market Positioning of Key Players, 2023
Strategies Adopted by Key Market Players
Recent Activities in the Market
Key Companies Market Share (%), 2023

Key Company Profiles

Eurofins Scientific (Luxembourg)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Laboratory Corporation of America Holdings (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
SGS S.A. (Switzerland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Charles River Laboratories (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
WuXi AppTec Co. Ltd. (China)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Element Materials Technology (UK)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Thermo Fisher Scientific, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Pace Analytical Services LLC (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Intertek Group plc (UK)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
IQVIA Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Merck KGaA (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Source BioScience (UK)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Almac Group (UK)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
ICON Plc (Ireland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Frontage Laboratories, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
STERIS Plc (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Sartorius AG (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
ALS Life Science (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Syneos Health, INC (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Medpace Holdings, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments